Friday, 16 June 2017

Discharge drugs illegal


High-Intensity UltraSound cures heart disease. 8W 1MHz will cure coronary heart disease – but medics will not use this bet medicine, as they get to prescribe no drugs. So ½ a minute of High-Intensity UltraSound to each area totally clears the disease for ever.
They prefer prescribing Ace-Inhibitors, Statins and 4 other drugs. The are peripheral t the heart disease – so they do not actually stop early death. They are the drugs they would give you, until your heart disease killed you.
High-Intensity UltraSound to the top left of the chest and kidneys totally clears the disease.
I gave it to me nursing friend Clive, who has 2 heart attacks six months apart 3 years ago: Without High-Intensity UltraSound he shuld have died 2.5 years ago.
So Salford Royal discharged him after 3 years – with a life time's prescriptions of the defective drugs: for no clinical reason – they just have warehouses full of the drugs.
High-Intensity UltraSound clears bacterial structures – which causes the heart disease. So Ace Inhibitors have no purpose. Prescribing useless drugs to the well is specifically prohibited by the Hippocratic oath.
Statins are anti-cholesterol drugs, but when the bacterial structure was clear, when cholesterol balance of the body was normalised – Statins serve no medical purpose – again illegal.
Every Dr in the medical team ceases to be a Dr.
Another friend's daughter has MS: High-Intensity UltraSound for ½ a minute to each side of the head in a totally benign way to clear the disease. My nursing friends is aghast – you are wrong, we must prescribe the same drugs that make MS such a potent killer.
So High-Intensity UltraSound totally clears MS, Alzheimer's, Parkinson's and Schizophrenia – obvious best medicine Dr.s and nurses MUST use: but don't.

So Chris was fully discharged from heart care. With a life time's drugs – that serve no purpose – totally illegal. Because without High-Intensity UltraSound he would have died medicated in 2015.
These pricey cholesterol drugs aren’t selling. And that has the biotech industry sweating

No comments: